Balloon drug coating and drug balloon

A drug coating and balloon technology, applied in the field of medical supplies, can solve problems such as drug inability to release, lower burst pressure, increase in drug adsorption, etc., to improve release efficiency and utilization rate, increase contact surface area, and increase drug amount Effect

Active Publication Date: 2021-02-19
DK MEDICAL TECH CO LTD
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] For example, Braun Medical in Germany took the lead in commercializing the paccocath drug-eluting balloon technology. The paclitaxel-releasing coronary balloon catheter named sequent please uses paclitaxel as the active drug and iopromide contrast agent Uvitamin as the carrier. Although the product has achieved a certain effect in clinical application, the drug coating of Braun's commercially available balloon is in a solid form and has no viscosity, which affects the performance of the drug coating; surface conditions, such as figure 1 As shown, the drug coating on its surface is in the form of particles of uneven size and uneven distribution on the surface of the balloon. The shear force of the blood makes the drug on the surface of the balloon easier to be washed away by the blood during the delivery of the balloon catheter. When the drug coating of the capsule is in contact with the lesion, a certain gap is generated, and only part of the protruding drug coating particles can adhere to the blood vessel wall, thus adversely affecting the drug release to the blood vessel wall
[0007] As another example, Chinese patent application CN201610808118.6 discloses a protective film with several sealing gaps outside the drug coating to avoid drug loss during delivery, and release the drug when the balloon expands to make the sealing gaps of the protective film Expansion, so that the drug is released from the gap to improve the drug utilization, but because most of the area of ​​the drug coating is still enclosed in the protective film when the balloon is expanded, it is isolated and cannot directly contact the blood vessel wall. Small contact area also adversely affects drug release
[0008] The inflation time of drug-coated balloons generally does not exceed 1 minute during use, and the drug must be effectively transferred from the surface of the balloon to the vessel wall within one minute. In such a short period of time, there will still be a large amount of Drug residues on the surface of the balloon cannot be released, resulting in low drug utilization
[0009] On the other hand, during the blood vessel delivery of the drug balloon, the drug content on the surface of the balloon will be lost due to the washing of blood or the dissolution of the drug in the blood, which will affect the amount of drug that can be delivered from the surface of the balloon to the lesion.
[0010] Chinese patent application CN201010121627.4 designed the outer surface of the balloon to have a concave-convex non-planar structure, so that the amount of adsorbed drug can be increased, and at the same time, the drug adsorbed on the outer wall of the balloon can be kept from being washed away by the blood in the blood vessel as much as possible. But it will cause damage to the balloon and affect its rated burst pressure
[0011] In Chinese patent application 201410289533.6, plasma etching method is used to form a nano-scale microporous structure on the surface of the balloon to improve the binding force between the surface of the balloon and the drug coating, increase the drug loading and avoid loss during drug delivery, but the plasma Etching has an effect on the performance of the balloon, reducing its burst pressure
Due to the large number of cycles of electrostatic self-assembly, the drug amount can be superimposed layer by layer, but because the surface charge gradually decreases after three times, the drug amount and binding force of the outer layer assembly show a downward trend

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Balloon drug coating and drug balloon
  • Balloon drug coating and drug balloon
  • Balloon drug coating and drug balloon

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] 1) Mix paclitaxel, triglyceride and acetone according to the mass ratio of 1:5:44, heat and stir at a constant temperature until the paclitaxel and triglyceride are completely dissolved to form a medicinal solution.

[0062] 2) Pre-fold the balloon to form creases.

[0063] 3) Inject the prepared drug solution into the spraying equipment, adjust the drug delivery speed of the syringe to 20ul / min, the power of the ultrasonic device to 30 watts, control the pressure inside the balloon to 2atm, and the balloon rotation speed to 3 revolutions / second, linear reciprocating motion at 0.3mm / s, spraying from one end of the balloon to the other end is a spraying cycle, and a total of 10 cycles of spraying are carried out.

[0064] 4) After the acetone volatilizes, a balloon coated with a balloon drug coating is obtained.

[0065] 5) Folding and shaping the balloon coated with the balloon drug coating.

Embodiment 2

[0067] The paclitaxel, triglyceride and acetone were mixed according to the mass ratio of 1:4:20.

[0068] Other processes and conditions are the same as those in Embodiment 1, and will not be repeated here.

Embodiment 3

[0070] The paclitaxel, triglyceride and acetone were mixed according to the mass ratio of 2:8:5.

[0071] Other processes and conditions are the same as those in Embodiment 1, and will not be repeated here.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a balloon drug coating and a drug balloon, which include nanoscale and / or microscale excipient particles and drug particles. The invention is exquisitely designed, so that the coating particles of the balloon drug coating are micron and / or nano-sized, and the formed balloon drug coating has a very large surface area. On the one hand, it can increase the contact surface area between the drug and the balloon. In this way, the binding force with the balloon can be improved. On the other hand, the contact area between the balloon and the blood vessel wall can be increased after the balloon is inflated and expanded, so that the drug particles can fully contact the blood vessel wall and adhere to the blood vessel surface quickly and evenly, so that Drugs can be quickly released to the blood vessel wall, thereby improving drug release efficiency and utilization.

Description

technical field [0001] The invention relates to the field of medical supplies, in particular to a balloon drug coating and a drug balloon. Background technique [0002] Angioplasty is a vascular interventional technique that involves the mechanical widening of blocked blood vessels, often caused by atherosclerosis. Typically a catheter with a tightly folded balloon is inserted into the patient's vasculature and delivered to the lesion site where pressure is used to inflate the balloon. The balloon can be inflated to a certain diameter and length. Percutaneous coronary intervention (PCI) of coronary angioplasty to treat narrowing of the coronary arteries of the heart. Percutaneous transluminal angioplasty (PTA) of peripheral vessels treats vessels other than coronary arteries. [0003] Balloon catheters are the most commonly used instruments for PCI procedures. The balloon catheter has a balloon and a catheter tubing, the balloon and the catheter tubing are connected and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): A61L29/16
CPCA61L29/16A61L2300/216A61L2300/416A61L2300/606
Inventor翁玉麟牛冬子石全刘宝瑞谷卓阳
OwnerDK MEDICAL TECH CO LTD